logo

Theriva Biologics Inc (TOVX) Stock: Navigating a Year of Volatility

CSCO Stock

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Theriva Biologics Inc’s current trading price is -93.89% away from its 52-week high, while its distance from the 52-week low is -21.56%. The stock’s price range for this period has been between $0.96 and $12.28 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 44.32 million for the day, a number notably higher than the average daily volume of 31430.0 over the last three months.

Theriva Biologics Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $12.28 on 05/09/24, while the lowest value for the same period was recorded at $0.96 on 05/07/25.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Theriva Biologics Inc (TOVX) has experienced a quarterly decline of -47.55% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.08M and boasts a workforce of 22 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.3555, with a change in price of -0.5133. Similarly, Theriva Biologics Inc recorded 718,185 in trading volume during the last 100 days, posting a change of -39.79%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for TOVX stands at 0.08. Similarly, the long-term debt-to-equity ratio is also 0.05.

TOVX Stock Stochastic Average

As of today, Theriva Biologics Inc’s raw stochastic average for the last 50 days stands at 2.11%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 2.11%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 52.35% and 70.02%, respectively.

TOVX Stock Price Performance Analysis

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Until today this year the stock’s price performance recorded a decrease of -57.14%. However, over the last six months, the performance has been stronger by -62.31%. The price of TOVX decreased -28.56% over the last 30 days. And in the last five days, it has fallen by -44.44%.

Most Popular